Presentation is loading. Please wait.

Presentation is loading. Please wait.

Use of Brilliant Blue FCF during vein graft preparation inhibits intimal hyperplasia  Michael J. Osgood, MD, Kevin Sexton, MD, Igor Voskresensky, MD, Kyle.

Published byJames Maximillian Goodwin Modified over 5 years ago

Similar presentations

Presentation on theme: "Use of Brilliant Blue FCF during vein graft preparation inhibits intimal hyperplasia  Michael J. Osgood, MD, Kevin Sexton, MD, Igor Voskresensky, MD, Kyle."— Presentation transcript:

1 Use of Brilliant Blue FCF during vein graft preparation inhibits intimal hyperplasia 
Michael J. Osgood, MD, Kevin Sexton, MD, Igor Voskresensky, MD, Kyle Hocking, PhD, Jun Song, BA, Padmini Komalavilas, PhD, Colleen Brophy, MD, Joyce Cheung-Flynn, PhD  Journal of Vascular Surgery  Volume 64, Issue 2, Pages (August 2016) DOI: /j.jvs Copyright © Terms and Conditions

2 Fig 1 Brilliant Blue FCF (FCF) inhibited platelet-derived growth factor (PDGF)-mediated migration in rat vascular smooth muscle cells. Migration of A7r5 cells was measured in a scratch assay in six-well plates. Cells were pretreated without (control) or with FCF (25 and 50 μM) before stimulation with PDGF. A, Cells invading the scratch were counted after 24 and 48 hours. Results are reported as relative increase in cell number compared with the control (n ≥ 4). The range bars show the standard error of the mean. *P < .05. B, Photomicrographs of representative experiment at 0 (unstimulated) and 48 hours (original magnification ×40). Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © Terms and Conditions

3 Fig 2 Brilliant Blue FCF (FCF) inhibited platelet-derived growth factor (PDGF)-mediated proliferation in rat vascular smooth muscle cells. Proliferation of A7r5 cells was measured using a tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay in 96-well plates. Cells were pretreated without (control) or with different concentrations of FCF before PDGF stimulation. Each treatment was performed in at least six wells and averaged for each assay. Results are reported as relative increase in absorbance compared with the unstimulated control (n = 6). The range bars show the standard error of the mean. *P < .05, **P < .005, n.s., nonsignificant. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © Terms and Conditions

4 Fig 3 Brilliant Blue FCF (FCF) treatment during graft explantation reduced intimal hyperplasia in the rabbit carotid interposition graft model. The external jugular veins (EJVs) from rabbits were stored in heparinized PlasmaLyte (HP) without (control) or supplemented with 50 μM FCF during a 60-minute explantation period before implantation into the carotid artery. Grafts were harvested after 28 days and stained to visualize the elastic lamina. Intimal and medial thickness were measured. A, Representative grafts stained with Verhoeff-Van Gieson in control or FCF-treated animals. The boxed areas in the top row (original magnification ×20) are shown in the bottom row (original magnification ×40). Scale bar = 50 μm. L, Lumen; M, media. The arrows indicate internal elastic lamina, and the white lines indicate the intimal thickness. B, Intimal thickness and (C) intimal-to-medial thickness (I/M) ratio were determined (n = 13). The range bars show the standard error of the mean. *P < .05. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © Terms and Conditions

5 Fig 4 Brilliant blue FCF (FCF) pretreatment reduced the intimal thickness of human saphenous vein (HSV) in organ culture. HSV rings were left untreated (control) or pretreated with FCF (50 μM) for 2 hours before culture in Roswell Park Memorial Institute medium supplemented with 30% fetal bovine serum for 14 days. Veins were stained to visualize the elastic lamina, and intimal layer thickening was measured. A, Results are presented as the relative change in intimal thickness compared with preculture rings (n = 8). The range bars indicate the standard error of the mean. *P = B, Representative Verhoeff-Van Gieson stained HSV. The white lines indicate the intimal thickness. Scale bar = 500 μm. L, Lumen; M, media. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © Terms and Conditions

Download ppt "Use of Brilliant Blue FCF during vein graft preparation inhibits intimal hyperplasia  Michael J. Osgood, MD, Kevin Sexton, MD, Igor Voskresensky, MD, Kyle."

Similar presentations

Orally administered penicillamine is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein–carotid artery interposition grafts 

Orally administered penicillamine is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein–carotid artery interposition grafts 
The Role of ex-vivo Gene Therapy of Vein Grafts with Egr-1 Decoy in the Suppression of Intimal Hyperplasia  M. Peroulis, J. Kakisis, A. Kapelouzou, A.

The Role of ex-vivo Gene Therapy of Vein Grafts with Egr-1 Decoy in the Suppression of Intimal Hyperplasia  M. Peroulis, J. Kakisis, A. Kapelouzou, A.
Cyclic adenosine monophosphate response-element binding protein activation by mitogen-activated protein kinase-activated protein kinase 3 and four-and-a-half.

Cyclic adenosine monophosphate response-element binding protein activation by mitogen-activated protein kinase-activated protein kinase 3 and four-and-a-half.
Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice  Daniël Eefting,

Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice  Daniël Eefting,
Inhibition of intimal thickening after vascular injury with a cocktail of vascular endothelial growth factor and cyclic Arg-Gly-Asp peptide  Yue Li, Lucinda.

Inhibition of intimal thickening after vascular injury with a cocktail of vascular endothelial growth factor and cyclic Arg-Gly-Asp peptide  Yue Li, Lucinda.
Bioengineered vascular access maintains structural integrity in response to arteriovenous flow and repeated needle puncture  Bryan W. Tillman, MD, PhD,

Bioengineered vascular access maintains structural integrity in response to arteriovenous flow and repeated needle puncture  Bryan W. Tillman, MD, PhD,
Dipeptidyl peptidase 4 inhibitor reduces intimal hyperplasia in rabbit autologous jugular vein graft under poor distal runoff  Akio Koyama, MD, Kimihiro.

Dipeptidyl peptidase 4 inhibitor reduces intimal hyperplasia in rabbit autologous jugular vein graft under poor distal runoff  Akio Koyama, MD, Kimihiro.
Inhibition of smooth muscle cell migration and neointima formation in vein grafts by overexpression of matrix metalloproteinase-3  Klaus Kallenbach, MD,

Inhibition of smooth muscle cell migration and neointima formation in vein grafts by overexpression of matrix metalloproteinase-3  Klaus Kallenbach, MD,
Synthetic smooth muscle cell phenotype is associated with increased nicotinamide adenine dinucleotide phosphate oxidase activity: Effect on collagen secretion 

Synthetic smooth muscle cell phenotype is associated with increased nicotinamide adenine dinucleotide phosphate oxidase activity: Effect on collagen secretion 
Cyclic adenosine monophosphate response-element binding protein activation by mitogen-activated protein kinase-activated protein kinase 3 and four-and-a-half.

Cyclic adenosine monophosphate response-element binding protein activation by mitogen-activated protein kinase-activated protein kinase 3 and four-and-a-half.
Zinc finger protein 191 deficiency attenuates vascular smooth muscle cell proliferation, migration, and intimal hyperplasia after endovascular arterial.

Zinc finger protein 191 deficiency attenuates vascular smooth muscle cell proliferation, migration, and intimal hyperplasia after endovascular arterial.
Effect of tissue plasminogen activator on vascular smooth muscle cells

Effect of tissue plasminogen activator on vascular smooth muscle cells
Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production 

Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production 
Ezetimibe reduces intimal hyperplasia in rabbit jugular vein graft

Ezetimibe reduces intimal hyperplasia in rabbit jugular vein graft
Alexey V. Kamenskiy, PhD, Iraklis I. Pipinos, MD, PhD, Jeffrey S

Alexey V. Kamenskiy, PhD, Iraklis I. Pipinos, MD, PhD, Jeffrey S
Growth factors and experimental arterial grafts

Growth factors and experimental arterial grafts
Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model  Jianping Dai, MD, PhD, Liliane.

Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model  Jianping Dai, MD, PhD, Liliane.
The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling 

The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling 
Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice  Daniël Eefting,

Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice  Daniël Eefting,
Dipeptidyl peptidase 4 inhibitor reduces intimal hyperplasia in rabbit autologous jugular vein graft under poor distal runoff  Akio Koyama, MD, Kimihiro.

Dipeptidyl peptidase 4 inhibitor reduces intimal hyperplasia in rabbit autologous jugular vein graft under poor distal runoff  Akio Koyama, MD, Kimihiro.

Similar presentations

Ads by Google